ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/29 | 1,352 | 1,393 | 1,352 | 1,383 | +35 | +2.6% | 379,400 |
| 2022/03/28 | 1,380 | 1,384 | 1,332 | 1,348 | -59 | -4.2% | 566,600 |
| 2022/03/25 | 1,457 | 1,461 | 1,342 | 1,407 | -38 | -2.6% | 998,500 |
| 2022/03/24 | 1,386 | 1,456 | 1,384 | 1,445 | +29 | +2% | 705,900 |
| 2022/03/23 | 1,381 | 1,425 | 1,375 | 1,416 | +65 | +4.8% | 796,600 |
| 2022/03/22 | 1,301 | 1,400 | 1,294 | 1,351 | +26 | +2% | 675,400 |
| 2022/03/18 | 1,272 | 1,331 | 1,260 | 1,325 | +56 | +4.4% | 775,900 |
| 2022/03/17 | 1,243 | 1,281 | 1,232 | 1,269 | +61 | +5% | 775,100 |
| 2022/03/16 | 1,241 | 1,246 | 1,188 | 1,208 | -5 | -0.4% | 711,200 |
| 2022/03/15 | 1,255 | 1,259 | 1,205 | 1,213 | -86 | -6.6% | 741,300 |
| 2022/03/14 | 1,283 | 1,307 | 1,275 | 1,299 | +18 | +1.4% | 426,800 |
| 2022/03/11 | 1,290 | 1,312 | 1,255 | 1,281 | -24 | -1.8% | 707,100 |
| 2022/03/10 | 1,332 | 1,336 | 1,294 | 1,305 | +18 | +1.4% | 555,800 |
| 2022/03/09 | 1,362 | 1,367 | 1,282 | 1,287 | -61 | -4.5% | 898,100 |
| 2022/03/08 | 1,380 | 1,430 | 1,334 | 1,348 | -29 | -2.1% | 1,273,200 |
| 2022/03/07 | 1,390 | 1,415 | 1,346 | 1,377 | -59 | -4.1% | 955,600 |
| 2022/03/04 | 1,428 | 1,445 | 1,370 | 1,436 | -21 | -1.4% | 1,305,900 |
| 2022/03/03 | 1,475 | 1,483 | 1,434 | 1,457 | -14 | -1% | 1,170,300 |
| 2022/03/02 | 1,393 | 1,483 | 1,380 | 1,471 | +38 | +2.7% | 1,666,600 |
| 2022/03/01 | 1,446 | 1,462 | 1,392 | 1,433 | +167 | +13.2% | 2,780,500 |
| 2022/02/28 | 1,158 | 1,278 | 1,158 | 1,266 | +81 | +6.8% | 1,339,000 |
| 2022/02/25 | 1,132 | 1,191 | 1,106 | 1,185 | +134 | +12.7% | 1,376,300 |
| 2022/02/24 | 1,095 | 1,099 | 1,033 | 1,051 | -67 | -6% | 1,533,100 |
| 2022/02/22 | 1,257 | 1,265 | 1,110 | 1,118 | -180 | -13.9% | 2,652,900 |
| 2022/02/21 | 1,205 | 1,310 | 1,204 | 1,298 | +94 | +7.8% | 2,141,800 |
| 2022/02/18 | 1,215 | 1,243 | 1,142 | 1,204 | -41 | -3.3% | 1,591,700 |
| 2022/02/17 | 1,233 | 1,269 | 1,212 | 1,245 | -10 | -0.8% | 903,800 |
| 2022/02/16 | 1,250 | 1,291 | 1,225 | 1,255 | +44 | +3.6% | 1,322,000 |
| 2022/02/15 | 1,172 | 1,355 | 1,140 | 1,211 | +69 | +6% | 3,873,300 |
| 2022/02/14 | 1,130 | 1,149 | 1,111 | 1,142 | -28 | -2.4% | 585,900 |
| 2022/02/10 | 1,161 | 1,192 | 1,161 | 1,170 | +25 | +2.2% | 631,900 |
| 2022/02/09 | 1,123 | 1,153 | 1,074 | 1,145 | +36 | +3.2% | 814,300 |
| 2022/02/08 | 1,147 | 1,148 | 1,106 | 1,109 | -22 | -1.9% | 431,500 |
| 2022/02/07 | 1,163 | 1,189 | 1,129 | 1,131 | -21 | -1.8% | 580,300 |
| 2022/02/04 | 1,153 | 1,183 | 1,125 | 1,152 | -12 | -1% | 630,100 |
| 2022/02/03 | 1,141 | 1,194 | 1,126 | 1,164 | +5 | +0.4% | 953,200 |
| 2022/02/02 | 1,095 | 1,176 | 1,095 | 1,159 | +69 | +6.3% | 1,187,200 |
| 2022/02/01 | 1,042 | 1,107 | 1,031 | 1,090 | +49 | +4.7% | 1,490,500 |
| 2022/01/31 | 935 | 1,112 | 918 | 1,041 | -144 | -12.2% | 4,188,000 |
| 2022/01/28 | 1,200 | 1,217 | 1,150 | 1,185 | -8 | -0.7% | 1,050,400 |
| 2022/01/27 | 1,247 | 1,260 | 1,189 | 1,193 | -67 | -5.3% | 1,120,600 |
| 2022/01/26 | 1,258 | 1,274 | 1,220 | 1,260 | +14 | +1.1% | 727,400 |
| 2022/01/25 | 1,348 | 1,364 | 1,234 | 1,246 | -102 | -7.6% | 1,548,300 |
| 2022/01/24 | 1,366 | 1,369 | 1,326 | 1,348 | -48 | -3.4% | 762,100 |
| 2022/01/21 | 1,457 | 1,462 | 1,378 | 1,396 | -58 | -4% | 697,900 |
| 2022/01/20 | 1,401 | 1,455 | 1,398 | 1,454 | +44 | +3.1% | 538,500 |
| 2022/01/19 | 1,379 | 1,422 | 1,378 | 1,410 | +6 | +0.4% | 474,100 |
| 2022/01/18 | 1,411 | 1,446 | 1,394 | 1,404 | +25 | +1.8% | 614,500 |
| 2022/01/17 | 1,400 | 1,414 | 1,376 | 1,379 | -23 | -1.6% | 292,900 |
| 2022/01/14 | 1,381 | 1,405 | 1,347 | 1,402 | +7 | +0.5% | 604,100 |
751～
800
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 218,100円 | +21.7% | +999.9% | 0.00% | 9.08倍 | 3.00倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 231,200円 | +14.2% | +41.0% | 1.99% | 11.32倍 | 1.15倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 304,500円 | +3.0% | +27.5% | 2.63% | 19.28倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 222,000円 | +0.4% | -8.4% | 2.39% | 28.50倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
